These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 24508508)

  • 41. Rapamycin and mTOR inhibitors probably have therapeutic effects for post-operative cognitive dysfunction.
    Yang C; Zhu B; Shen J; Hu T; Li Z; Hong T
    Med Hypotheses; 2013 Sep; 81(3):487-8. PubMed ID: 23850396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From rapalogs to anti-aging formula.
    Blagosklonny MV
    Oncotarget; 2017 May; 8(22):35492-35507. PubMed ID: 28548953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. mTOR, glycotoxins and the parallel universe.
    Green AS
    Aging (Albany NY); 2018 Dec; 10(12):3654-3656. PubMed ID: 30540565
    [No Abstract]   [Full Text] [Related]  

  • 44. Rapamycin, a mTOR inhibitor, induced growth inhibition in retinoblastoma Y79 cell via down-regulation of Bmi-1.
    Wang YD; Su YJ; Li JY; Yao XC; Liang GJ
    Int J Clin Exp Pathol; 2015; 8(5):5182-8. PubMed ID: 26191215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells.
    Facompre ND; Sinha I; El-Bayoumy K; Pinto JT; Sinha R
    Int J Cancer; 2012 Nov; 131(9):2134-42. PubMed ID: 22307455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Duration of rapamycin treatment has differential effects on metabolism in mice.
    Fang Y; Westbrook R; Hill C; Boparai RK; Arum O; Spong A; Wang F; Javors MA; Chen J; Sun LY; Bartke A
    Cell Metab; 2013 Mar; 17(3):456-62. PubMed ID: 23473038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. mTOR inhibition: a double-edged sword in patients with COVID-19?
    Ghasemnejad-Berenji M
    Hum Cell; 2021 Mar; 34(2):698-699. PubMed ID: 33527306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of mammalian target of rapamycin induces lipid accumulation in the diaphragm of ventilated rats and hypoxia-treated C2C12 cells.
    Yu T; Wang M; Wen Y; Cao Y; Shen G; Jiang X; Wu J; Lu W; Jin X
    J Surg Res; 2018 May; 225():82-89. PubMed ID: 29605039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapamycin, anti-aging, and avoiding the fate of Tithonus.
    Richardson A
    J Clin Invest; 2013 Aug; 123(8):3204-6. PubMed ID: 24063054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapamycin extends murine lifespan but has limited effects on aging.
    Neff F; Flores-Dominguez D; Ryan DP; Horsch M; Schröder S; Adler T; Afonso LC; Aguilar-Pimentel JA; Becker L; Garrett L; Hans W; Hettich MM; Holtmeier R; Hölter SM; Moreth K; Prehn C; Puk O; Rácz I; Rathkolb B; Rozman J; Naton B; Ordemann R; Adamski J; Beckers J; Bekeredjian R; Busch DH; Ehninger G; Graw J; Höfler H; Klingenspor M; Klopstock T; Ollert M; Stypmann J; Wolf E; Wurst W; Zimmer A; Fuchs H; Gailus-Durner V; Hrabe de Angelis M; Ehninger D
    J Clin Invest; 2013 Aug; 123(8):3272-91. PubMed ID: 23863708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Role of mTOR Signaling as a Therapeutic Target in Cancer.
    Popova NV; Jücker M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Mammalian target of rapamycin inhibitors for the targeted therapy of non-small cell lung cancer].
    Lin Y; Zhang L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Apr; 32(2):239-42. PubMed ID: 20450558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mammalian target of rapamycin and tuberous sclerosis complex.
    Wataya-Kaneda M
    J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dissecting mammalian target of rapamycin to promote longevity.
    Mendelsohn AR; Larrick JW
    Rejuvenation Res; 2012 Jun; 15(3):334-7. PubMed ID: 22758368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of mTOR signaling pathway in spinal cord injury.
    Kanno H; Ozawa H; Sekiguchi A; Yamaya S; Tateda S; Yahata K; Itoi E
    Cell Cycle; 2012 Sep; 11(17):3175-9. PubMed ID: 22895182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. mTOR signaling in neural stem cells: from basic biology to disease.
    Magri L; Galli R
    Cell Mol Life Sci; 2013 Aug; 70(16):2887-98. PubMed ID: 23124271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of the TOR pathway in mediating the link between nutrition and longevity.
    Lushchak O; Strilbytska O; Piskovatska V; Storey KB; Koliada A; Vaiserman A
    Mech Ageing Dev; 2017 Jun; 164():127-138. PubMed ID: 28315697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New Mammalian Target of Rapamycin (mTOR) Modulators Derived from Natural Product Databases and Marine Extracts by Using Molecular Docking Techniques.
    Ruiz-Torres V; Losada-Echeberría M; Herranz-López M; Barrajón-Catalán E; Galiano V; Micol V; Encinar JA
    Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30326670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. mTOR signaling and drug development in cancer.
    Dancey J
    Nat Rev Clin Oncol; 2010 Apr; 7(4):209-19. PubMed ID: 20234352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction.
    Miller RA; Harrison DE; Astle CM; Fernandez E; Flurkey K; Han M; Javors MA; Li X; Nadon NL; Nelson JF; Pletcher S; Salmon AB; Sharp ZD; Van Roekel S; Winkleman L; Strong R
    Aging Cell; 2014 Jun; 13(3):468-77. PubMed ID: 24341993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.